These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8619644)

  • 21. Breast cancer chemoprevention: additional observations.
    Singh-Ranger G; Mokbel K
    Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
    [No Abstract]   [Full Text] [Related]  

  • 22. [-Tamoxifen and the endometrium: monitoring and evaluation of endometrial changes-].
    Rageth JC; Bronz L; Granberg S
    Arch Gynecol Obstet; 1995; 256 Suppl():S122-7. PubMed ID: 8619646
    [No Abstract]   [Full Text] [Related]  

  • 23. Venous thromboembolic disease and stroke in women taking tamoxifen for breast cancer chemoprevention.
    Isaacs C
    Clin Adv Hematol Oncol; 2005 Dec; 3(12):913-4. PubMed ID: 16555431
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemoprevention of breast cancer.
    Mahon SM
    Clin J Oncol Nurs; 2004 Aug; 8(4):421-3. PubMed ID: 15354932
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
    Reichert D; Illiger HJ
    Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
    [No Abstract]   [Full Text] [Related]  

  • 26. Give us clear, not convoluted, clinical practice guidelines.
    Sehmer J
    CMAJ; 2001 Nov; 165(11):1468-9. PubMed ID: 11762568
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
    Kattan J; Ghosn M
    J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial.
    Decensi A; Maisonneuve P; Rotmensz N; Bettega D; Costa A; Sacchini V; Salvioni A; Travaglini R; Oliviero P; D'Aiuto G; Gulisano M; Gucciardo G; del Turco MR; Pizzichetta MA; Conforti S; Bonanni B; Boyle P; Veronesi U;
    Circulation; 2005 Feb; 111(5):650-6. PubMed ID: 15699284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer prevention with tamoxifen.
    Haden K; Santen R
    Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
    Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First do no harm: extending the debate on the provision of preventive tamoxifen.
    Will BP; Nobrega KM; Berthelot JM; Flanagan W; Wolfson MC; Logan DM; Evans WK
    Br J Cancer; 2001 Nov; 85(9):1280-8. PubMed ID: 11720461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
    Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer risk in primary care: implications for chemoprevention.
    Lewis CL; Kinsinger LS; Harris RP; Schwartz RJ
    Arch Intern Med; 2004 Sep; 164(17):1897-903. PubMed ID: 15451765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 36. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.
    Formelli F; Camerini T; Cavadini E; Appierto V; Villani MG; Costa A; De Palo G; Di Mauro MG; Veronesi U
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):34-41. PubMed ID: 12540501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.
    Costa A; De Palo G; Decensi A; Formelli F; Chiesa F; Nava M; Camerini T; Marubini E; Veronesi U
    Ann N Y Acad Sci; 1995 Sep; 768():148-62. PubMed ID: 8526344
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
    Costa A; Formelli F; Chiesa F; Decensi A; De Palo G; Veronesi U
    Cancer Res; 1994 Apr; 54(7 Suppl):2032s-2037s. PubMed ID: 8137334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USPSTF releases guidelines on breast-cancer chemoprevention.
    Bradbury J
    Lancet; 2002 Jul; 360(9326):63. PubMed ID: 12114050
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen Chemoprevention--End of the Road?
    Narod SA
    JAMA Oncol; 2015 Nov; 1(8):1033-4. PubMed ID: 26247918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.